317 related articles for article (PubMed ID: 11368354)
1. Phosphorylation of Bcl2 and regulation of apoptosis.
Ruvolo PP; Deng X; May WS
Leukemia; 2001 Apr; 15(4):515-22. PubMed ID: 11368354
[TBL] [Abstract][Full Text] [Related]
2. Bcl2's flexible loop domain regulates p53 binding and survival.
Deng X; Gao F; Flagg T; Anderson J; May WS
Mol Cell Biol; 2006 Jun; 26(12):4421-34. PubMed ID: 16738310
[TBL] [Abstract][Full Text] [Related]
3. Mono- and multisite phosphorylation enhances Bcl2's antiapoptotic function and inhibition of cell cycle entry functions.
Deng X; Gao F; Flagg T; May WS
Proc Natl Acad Sci U S A; 2004 Jan; 101(1):153-8. PubMed ID: 14660795
[TBL] [Abstract][Full Text] [Related]
4. Regulation of Bcl2 phosphorylation and potential significance for leukemic cell chemoresistance.
Deng X; Kornblau SM; Ruvolo PP; May WS
J Natl Cancer Inst Monogr; 2001; (28):30-7. PubMed ID: 11158204
[TBL] [Abstract][Full Text] [Related]
5. Reversible phosphorylation of Bcl2 following interleukin 3 or bryostatin 1 is mediated by direct interaction with protein phosphatase 2A.
Deng X; Ito T; Carr B; Mumby M; May WS
J Biol Chem; 1998 Dec; 273(51):34157-63. PubMed ID: 9852076
[TBL] [Abstract][Full Text] [Related]
6. Protein phosphatase 2A inactivates Bcl2's antiapoptotic function by dephosphorylation and up-regulation of Bcl2-p53 binding.
Deng X; Gao F; May WS
Blood; 2009 Jan; 113(2):422-8. PubMed ID: 18845789
[TBL] [Abstract][Full Text] [Related]
7. Survival function of ERK1/2 as IL-3-activated, staurosporine-resistant Bcl2 kinases.
Deng X; Ruvolo P; Carr B; May WS
Proc Natl Acad Sci U S A; 2000 Feb; 97(4):1578-83. PubMed ID: 10677502
[TBL] [Abstract][Full Text] [Related]
8. Posttranslational modifications of Bcl2 family members--a potential therapeutic target for human malignancy.
Basu A; DuBois G; Haldar S
Front Biosci; 2006 May; 11():1508-21. PubMed ID: 16368533
[TBL] [Abstract][Full Text] [Related]
9. BCL2 promotor methylation and miR-15a/16-1 upregulation is associated with sanguinarine-induced apoptotic death in rat HSC-T6 cells.
Zhang DS; Li YY; Chen XJ; Li YJ; Liu ZY; Xie WJ; Sun ZL
J Pharmacol Sci; 2015 Jan; 127(1):135-44. PubMed ID: 25704029
[TBL] [Abstract][Full Text] [Related]
10. Signal-induced site specific phosphorylation targets Bcl2 to the proteasome pathway.
Basu A; Haldar S
Int J Oncol; 2002 Sep; 21(3):597-601. PubMed ID: 12168105
[TBL] [Abstract][Full Text] [Related]
11. A functional role for nicotine in Bcl2 phosphorylation and suppression of apoptosis.
Mai H; May WS; Gao F; Jin Z; Deng X
J Biol Chem; 2003 Jan; 278(3):1886-91. PubMed ID: 12421819
[TBL] [Abstract][Full Text] [Related]
12. Functional Implications of the spectrum of BCL2 mutations in Lymphoma.
Singh K; Briggs JM
Mutat Res Rev Mutat Res; 2016; 769():1-18. PubMed ID: 27543313
[TBL] [Abstract][Full Text] [Related]
13. Bcl-xL overexpression inhibits progression of molecular events leading to paclitaxel-induced apoptosis of human acute myeloid leukemia HL-60 cells.
Ibrado AM; Liu L; Bhalla K
Cancer Res; 1997 Mar; 57(6):1109-15. PubMed ID: 9067280
[TBL] [Abstract][Full Text] [Related]
14. Serine-70 is one of the critical sites for drug-induced Bcl2 phosphorylation in cancer cells.
Haldar S; Basu A; Croce CM
Cancer Res; 1998 Apr; 58(8):1609-15. PubMed ID: 9563469
[TBL] [Abstract][Full Text] [Related]
15. Unwinding the loop of Bcl-2 phosphorylation.
Blagosklonny MV
Leukemia; 2001 Jun; 15(6):869-74. PubMed ID: 11417471
[TBL] [Abstract][Full Text] [Related]
16. Synchronised phosphorylation of BNIP3, Bcl-2 and Bcl-xL in response to microtubule-active drugs is JNK-independent and requires a mitotic kinase.
Mellor HR; Rouschop KM; Wigfield SM; Wouters BG; Harris AL
Biochem Pharmacol; 2010 Jun; 79(11):1562-72. PubMed ID: 20100468
[TBL] [Abstract][Full Text] [Related]
17. Bcl2 enhances induced hematopoietic differentiation of murine embryonic stem cells.
Wang YY; Deng X; Xu L; Gao F; Flagg T; May WS
Exp Hematol; 2008 Feb; 36(2):128-39. PubMed ID: 18023519
[TBL] [Abstract][Full Text] [Related]
18. BAX and PKCalpha modulate the prognostic impact of BCL2 expression in acute myelogenous leukemia.
Kornblau SM; Vu HT; Ruvolo P; Estrov Z; O'Brien S; Cortes J; Kantarjian H; Andreeff M; May WS
Clin Cancer Res; 2000 Apr; 6(4):1401-9. PubMed ID: 10778970
[TBL] [Abstract][Full Text] [Related]
19. PKC alpha mediates chemoresistance in acute lymphoblastic leukemia through effects on Bcl2 phosphorylation.
Jiffar T; Kurinna S; Suck G; Carlson-Bremer D; Ricciardi MR; Konopleva M; Andreeff M; Ruvolo PP
Leukemia; 2004 Mar; 18(3):505-12. PubMed ID: 14737078
[TBL] [Abstract][Full Text] [Related]
20. Low cleaved caspase-7 levels indicate unfavourable outcome across all breast cancers.
Lindner AU; Lucantoni F; Varešlija D; Resler A; Murphy BM; Gallagher WM; Hill ADK; Young LS; Prehn JHM
J Mol Med (Berl); 2018 Oct; 96(10):1025-1037. PubMed ID: 30069746
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
